Vabysmo 6 MG/0.05 ML syringe 0.05ML
Ended Awarded
- Contract number
- SPE2DB25FDQVK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,950
Award facts
- Contract value 100% obligated
- $8,950.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,950.32 by the Defense Logistics Agency (DLA) on June 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes, a pharmaceutical product used in ophthalmology treatment. This delivery order represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 vehicle that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies through firm fixed-price delivery orders. The contract is unencumbered by set-aside designations, and performance is slated for completion by June 27, 2025, at the company's Park Ridge, Illinois location.
DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA to support Department of Defense healthcare facilities nationwide. The company's portfolio encompasses an extensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and specialized medical consumables. This particular delivery order exemplifies the company's role in providing critical pharmaceutical products directly to military health facilities, reinforcing its positioning as a key vendor for the DLA's medical supply procurement operations.
Quick answers
Who was awarded contract SPE2DB25FDQVK?
SPE2DB25FDQVK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 5, 2025.
How much is contract SPE2DB25FDQVK worth?
The government has obligated $8,950 on SPE2DB25FDQVK.
Is contract SPE2DB25FDQVK an order under another contract?
Yes. SPE2DB25FDQVK is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQVK competed?
The extent of competition for SPE2DB25FDQVK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award